Macromolecules
Article
2.88 mmol). 1H NMR (500 MHz, CDCl3): δ 9.54 (s, 1H, OH), 7.17
(dd, JHH = 8.4, 2.4 Hz, 1H, ArCH), 6.94 (d, JHH = 2.4 Hz, 1H,
ArCH), 6.75 (d, JHH = 8.4, Hz, 1H, ArCH), 3.67 (s, 2H, ArCH2N),
2.46 (t, JHH = 7.4 Hz, 2H, CH2), 2.27 (s, 3H, NCH3), 1.59−1.48 (m,
2H, CH2), 1.27 (m, 27H, C(CH3)3, CH2), 0.88 (t, JHH = 7.0 Hz, 3H,
CH3). 13C NMR (126 MHz, CDCl3): δ 155.72 (s, 1C, ArCO), 141.66
(s, 1C, ArC), 125.37 (s, 1C, ArCH), 125.22 (s, 1C, ArCH), 121.34 (s,
1C, ArC), 115.45 (s, 1C, ArCH), 62.09 (s, 1C, ArCH2N), 57.38 (s,
1C, CH2), 41.34 (s, 1C, NCH3), 34.07 (s, 1C, C(CH3)3), 32.06 (s,
1C, CH2), 31.72 (s, 3C, C(CH3)3), 30.09−29.57 (m, 5C, CH2),
29.49 (s, 1C, CH2), 27.34 (s, 1C, CH2), 27.16 (s, 1C, CH2), 22.83 (s,
1C, CH2), 14.25 (s, 1C, CH3). Anal. calcd (found) for C24H43NO: C,
79.72 (79.14); H, 11.99 (11.57); N, 3.87 (3.51)%. ESI/MS calcd
(found): 361.33 (362.3) [M + 1]+.
NCH2), 3.57 (s, 3H, NCH3), 1.89−1.82 (m, 2H, CH2), 1.73−1.69
(m, 2H, CH2), 1.36 (s, 9H, C(CH3)3), 1.29−1.22 (m, 25H, CH2,
C(CH3)3), 0.88 (t, JHH = 6.9 Hz, 3H, CH3). 13C NMR (126 MHz,
CDCl3): δ 146.90 (s, 1C, ArC-O), 146.18 (s, 1C, ArC), 138.22 (s,
1C, ArC), 124.82 (s, 1C, ArCH), 122.14 (s, 1C, ArCH), 113.40 (s,
1C, ArC), 84.05 (s, 1C, OCH2N), 62.49 (s, 1C NCH2Ar), 60.91 (s,
1C, NCH2), 45.77 (s, 1C, NCH3), 35.01 (s, 1C, C(CH3)3), 34.24 (s,
1C, C(CH3)3), 31.83 (s, 1C, CH2), 31.47 (s, 3C, C(CH3)3), 29.83 (s,
3C, C(CH3)3), 29.78−29.20 (m, 6C, CH2), 26.45 (s, 1C, CH2),
22.80 (s, 1C, CH2), 22.42 (s, 1C, CH2), 14.24 (s, 1C, CH3). Anal.
calcd (found) for C29H52ClNO: C, 74.36 (74.72); H, 11.00 (11.24);
Cl, 7.43 (7.60); N, 2.89 (3.00)%. ESI/MS calcd (found): 430.40
(430.37) [M + 1]+. IR: 1230, 962 cm−1.
4.2.5. 6-(tert-Butyl)-3-dodecyl-3-methyl-3,4-dihydro-2H-benzo-
[e][1,3]oxazin-3-yl Chloride, H,tBuBxC12,Me. Synthesis was carried out
analogically as for the compound dtBuBxCy,Me by using appropriate
substrates as follows: compound H,tBuLC12,Me−H (0.50 g, 1.38 mmol),
NaH (0.041 g, 1.73 mmol, 1.25 equiv). Compound H,tBuBxC12,Me was
4.2.2. 6,8-Di-tert-butyl-3-cyclohexyl-3-methyl-3,4-dihydro-2H-
benzo[e][1,3]oxazin-3-yl Chloride, [dtBuBxCy,Me]Cl. To a solution of
Cy,Me
L
−H (0.50 g, 1.50 mmol) in 10 mL of the mixture of THF/
dtBu
CH2Cl2 (1/1), NaH (0.057 g, 1.89 mmol, 1.25 equiv) was added
under a inert atmosphere of N2. The slightly yellow solution was
stirred for 1 h until gas evolution disappeared. Then, the mixture was
evaporated to dryness and the 15 mL of CH2Cl2 was added for the
precipitation of NaCl. After filtration of NaCl, the filtrate was dried
1
obtained as a white powder, yield: (0.49 g, 1.19 mmol, 85%). H
NMR (500 MHz, CDCl3): δ 7.28 (dd, JHH = 8.6, 2.3 Hz, 1H, ArCH),
7.07 (d, JHH = 2.3 Hz, 1H, ArCH), 6.91 (d, JHH = 8.6 Hz, 1H, ArCH),
5.70 (d, JHH = 8.2 Hz, 1H, OCH2N), 5.46 (d, JHH = 8.2 Hz, 1H,
OCH2N), 5.16 (d, JHH = 15.3 Hz, 1H, NCH2Ar), 4.97 (d, JHH = 15.3
Hz, 1H, NCH2Ar), 3.84−3.64 (m, 2H, NCH2), 3.59 (s, 3H, NCH3),
1.94−1.73 (m, 2H, CH2), 1.40−1.30 (m, 2H, CH2), 1.26−1.16 (m,
25H, CH2, C(CH3)3), 0.84 (t, JHH = 6.9 Hz, 3H, CH3). 13C NMR
(126 MHz, CDCl3): δ 147.41 (s, 1C, ArC−O), 147.13 (s, 1C, ArC),
127.37 (s, 1C, ArCH), 124.32 (s, 1C, ArCH), 116.78 (s, 1C, ArCH),
113.11 (s, 1C, ArC), 84.37 (s, 1C, OCH2N), 60.42 (s, 1C, NCH2Ar),
59.49 (s, 1C, NCH2), 45.56 (s, 1C, NCH3), 34.52 (s, 1C, C(CH3)3),
31.96 (s, 1C, CH2), 31.39 (s, 3C, C(CH3)3), 30.08−28.49 (m, 6C,
CH2), 26.39 (s, 1C, CH2), 22.74 (s, 1C, CH2), 22.34 (s, 1C, CH2),
14.18 (s, 1C, CH3). Anal. calcd (found) for C25H44ClNO: C, 72.98
(73.22); H, 10.75 (10.81); Cl, 8.46 (8.65); N, 3.12 (3.42)%. ESI/MS
calcd (found): 374.34 (374.23) [M + 1]+. IR: 1232, 930 cm−1.
4.3. Thermal Measurement. TGA was performed using TGA/
DSC1 Mettler Toledo thermobalance coupled by heated at 230 °C
transfer line to a Nicolet iZ10 Thermo Scientific spectrometer.
Samples of 10−12 mg were heated with a rate of 10 °C/min from 25
to 1000 °C under 30 mL/min of nitrogen flow. FT-IR gas-phase
spectra were collected with a spectral resolution of 4 cm−1 with 32 co-
added scans.
DSC measurements were performed using the Mettler Toledo
DSC1 system, coupled with a Huber TC 100 intracooler. The
instrument was calibrated using indium (Tm = 156.6 °C, ΔHm = 28.45
J/g) and zinc (Tm = 419.7 °C, ΔHm = 107.00 J/g) standards. Samples
(∼3.5 mg) were measured in 40 μL aluminum pans under a constant
nitrogen purge (60 mL/min) from 0 to 300 °C with heating rate 10°
C/min. The TGA and DSC experimental data were processed using
the generic STARe computer program. For the purpose of data
presentation, the DSC, TGA, and FT-IR profiles were exported to
OriginPro 64 (v. 9.0) as ASCII files.
4.4. Details of X-Ray Data Analysis. X-ray diffraction data for a
suitable crystal of each sample were collected using a Xcalibur CCD
and S2) with a ω scan technique. The data collection and processing
utilized CrysAlis suite of programs.63 The space groups were
determined based on systematic absences and intensity statistics.
Lorentz polarization corrections were applied. The structures were
solved using intrinsic phasing SHELXT-2014/5 and refined by full-
matrix least-squares on F2. All calculations were performed using the
SHELX suite of programs.64 All non-hydrogen atoms were refined
with anisotropic displacement parameters. Hydrogen atom positions
were calculated with geometry and not allowed to vary. Thermal
ellipsoid plots were prepared with 50% of probability displacements
for non-hydrogen atoms by using Mercury 3.9 program.65 All data
have been deposited with the Cambridge Crystallographic Data
Centre CCDC-2002871 for isomer 1 of [dtBuBxCy,Me]Cl and -2002871
for isomer 2 of [dtBuBxCy,Me]Cl. Copies of the data can be obtained
over vacuum to give dtBuBxCy,Me as a white powder (0.51 g, 1.34
1
mmol) in 89% yield. H NMR (500 MHz, CDCl3): δ 7.27 (d, JHH
2.4 Hz, 1H, ArCH), 6.92 (d, JHH = 2.4 Hz, 1H, ArCH), 5.76 (d, JHH
=
=
8.6 Hz, 1H, NCH2O), 5.56 (d, JHH = 8.6 Hz, 1H, NCH2O), 5.24 (d,
HH = 15.3 Hz, 1H, NCH2Ar), 4.89 (d, JHH = 15.3 Hz, 1H, NCH2Ar),
J
3.89 (m, 1H, NCH), 3.42 (s, 3H, NCH3), 2.42−2.30 (m, 2H, CH2),
2.08−1.90 (m, 2H, CH2), 1.73−1.62 (m, 1H, CH2), 1.35−1.31 (m,
2H, CH2), 1.34 (s, 9H, C(CH3)3), 1.27 (s, 9H, C(CH3)3), 1.25−1.07
(m, 3H, CH2). 13C NMR (126 MHz, CDCl3): δ 154.92 (s, 1C, ArC-
O), 146.64 (s, 1C, ArC), 137.95 (s, 1C, ArC), 124.72 (s, 1C, ArCH),
123.59 (s, 1C, ArCH), 113.64 (s, 1C, ArC), 83.50 (s, 1C, OCH2N),
67.34 (s, 1C, NCH), 58.59 (s, 1C, NCH2Ar), 41.68 (s, 1C, NCH3),
34.99 (s, 1C, C(CH3)3), 34.72 (s, 1C, C(CH3)3), 31.47 (s, 3C,
C(CH3)3), 29.75 (s, 3C, C(CH3)3), 26.60−24.95 (m, 5C, CH2).
Anal. calcd (found) for C23H38ClNO: C, 72.64 (72.70); H, 9.89
(10.08); N, 3.51 (3.69)%. IR: 1230, 961 cm−1.
4.2.3. 6-(tert-Butyl)-3-cyclohexyl-3-methyl-3,4-dihydro-2H-
benzo[e][1,3]oxazin-3-yl Chloride, H,tBuBxCy,Me. Synthesis was carried
out analogically as for the compound dtCByu,BMxeCy,Me by using appropriate
substrates as follows: compound H,tBuL
−H (0.50 g, 1.80 mmol),
NaH (0.054 g, 2.27 mmol, 1.25 equiv). Compound H,tBuBxCy,Me was
1
obtained as a white powder. Yield: (0.54 g, 1.59 mmol, 88%). H
NMR (500 MHz, CDCl3): δ 7.28 (dd, JHH = 8.6, 2.3 Hz, 1H, ArCH),
7.07 (d, JHH = 2.3 Hz, 1H, ArCH), 6.91 (d, JHH = 8.6 Hz, 1H, ArCH),
5.70 (d, JHH = 8.6 Hz, 1H, OCH2N), 5.46 (d, JHH = 8.6 Hz, 1H,
OCH2N), 5.16 (d, JHH = 15.3 Hz, 1H, NCH2Ar), 4.97 (d, JHH = 15.3
Hz, 1H, NCH2Ar), 3.81 (m, 1H, NCH), 3.38 (s, 3H, NCH3), 2.35−
2.23 (m, 2H, CH2), 2.01−1.95 (m, 2H, CH2), 1.72−1.64 (m, 1H,
CH2), 1.62−1.54 (m, 2H, CH2), 1.45−1.34 (m, 2H, CH2), 1.26 (s,
9H, C(CH3)3), 1.20−1.04 (m, 1H, CH2). 13C NMR (126 MHz,
CDCl3): δ 148.65 (s, 1C, ArC−O), 147.72 (s, 1C, ArC), 127.39 (s,
1C, ArCH), 124.38 (s, 1C, ArCH), 116.77 (s, 1C, ArCH), 114.34 (s,
1C, ArC), 83.84 (s, 1C, OCH2N), 67.38 (s, 1C, NCH), 58.47 (s, 1C,
NCH2Ar), 41.69 (s, 1C, NCH3), 34.62 (s, 1C, C(CH3)3), 31.42 (s,
3C, C(CH3)3), 26.48 (s, 1C, CH2), 25.94 (s, 1C, CH2), 25.28 (s, 2C,
CH2), 24.88 (s, 1C, CH2). ESI/MS calcd (found): 303.26 (303.22)
[M + 1]+. Anal. calcd (found) for C20H33ClNO: C, 72.98 (73.22); H,
10.75 (10.81); Cl, 8.46 (8.65); N, 3.12 (3.42)%. IR: 1238, 954 cm−1.
4.2.4. 6,8-Di-tert-butyl-3-cyclohexyl-3-methyl-3,4-dihydro-2H-
benzo[e][1,3]oxazin-3-yl Chloride, dtBuBxC12,Me. Synthesis was carried
out analogically as for the compound dtBuBxCy,Me by using appropriate
C12,Me
substrates as follows: compound
L
−H (0.50 g, 1.20 mmol),
dtBu
NaH (0.036 g, 1.50 mmol, 1.25 equiv). Compound dtBuBxC12,Me was
obtained as a white powder. Yield: (0.52 g, 1.11 mmol, 92%). H
1
NMR (500 MHz, CDCl3): δ 7.31 (d, JHH = 2.0 Hz, 1H, ArCH), 6.92
(d, JHH = 2.0 Hz, 1H, ArCH), 5.62 (d, JHH = 8.2 Hz, 1H, OCH2N),
5.39 (d, JHH = 8.2 Hz, 1H, OCH2N), 5.11 (d, JHH = 15.3 Hz, 1H,
NCH2Ar), 4.88 (d, JHH = 15.3 Hz, 1H, NCH2Ar), 3.80−3.67 (m, 2H,
K
Macromolecules XXXX, XXX, XXX−XXX